First-in-Human Safety Study for Fractomer™ Biomatrix

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 30, 2026

Conditions

Soft TissueSoft Tissue DefectsSubcutaneous Injection

Interventions

DEVICE

Implantation (injection) of a new biomatrix for soft tissue support.

Implantation of a new injectable medical device, Fractomer Biomatrix, to study the safety of the product in healthy human participants.

Trial Locations (1)

Nucleus Network, Saint Paul

All Listed Sponsors

lead

inSoma Bio, Inc.

INDUSTRY

NCT07151638 - First-in-Human Safety Study for Fractomer™ Biomatrix | Biotech Hunter | Biotech Hunter